End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
183 SAR | -0.33% | -2.56% | +4.93% |
04-22 | Saudi Arabia's National Medical Care Co Declares FY23 Dividend | MT |
04-22 | National Medical Care Wins SAR380 Million Contract for Patient Care Services | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- With an expected P/E ratio at 28.6 and 23.87 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.93% | 2.2B | - | ||
-20.16% | 16.21B | B+ | ||
+4.50% | 12.44B | B | ||
+3.98% | 11.58B | B+ | ||
+9.72% | 10.79B | B+ | ||
-0.48% | 7.68B | A- | ||
+18.43% | 7.2B | D | ||
+4.49% | 6.67B | B- | ||
+50.89% | 4.66B | - | ||
-5.12% | 4.25B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 4005 Stock
- Ratings National Medical Care Company